In February, Congress finally took action to rein in PBMs via the Consolidated Appropriations Act of 2026. It included reforms like the delinking of PBM compensation from the price of a drug in ...

The blockbuster Sanofi and Regeneron Pharmaceuticals drug Dupixent, already commercialized in several skin and lung disorders, has expanded its FDA-approval to chronic obstructive pulmonary disease ...

Many healthcare AI startups are changing the way they charge for their technology, moving away from flat subscription rates and toward pricing linked to the financial impact of their tools. Investors ...

Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If ...

CEO Kempton Presley provided an overview of its medication adherence technology and how it addresses challenges specific to dual-eligibles. Vice President, Product Management, Data and Ecosystem ...

Grow Therapy's Series D funding was led by TCV and Growth Equity at Goldman Sachs Alternatives, with participation from BCI, Menlo Ventures, Sequoia, SignalFire and Transformation Capital.

An experimental drug that Theravance Biopharma touted as a potential first-in-class medicine for multiple system atrophy has failed a Phase 3 study, triggering a corporate shakeup that ends this ...

Health data company Health Gorilla filed a motion to dismiss a lawsuit from Epic and several healthcare providers alleging inappropriate access to nearly 300,000 patient records. The case highlights ...

Giving healthcare teams powerful AI tools without training undermines their ability to use potentially system-changing tools safely and effectively.

Access to primary care is collapsing in the U.S., creating an opening for new models that lower costs and improve outcomes. The new entity will be led by Premise CEO Stu Clark. He framed the deal as a ...

Congress reached a bipartisan agreement this week on a healthcare funding and policy package included in a larger $1.2 trillion spending bill aimed at averting a government shutdown. The package ...

New research emerged this month shining light on the need for wider use of continuous glucose monitors (CGMs). The study — which was conducted by CCS, a chronic care management company — analyzed data ...